The Supreme Court granted the Centre four weeks to submit a comprehensive compliance report on implementing its January 30 judgment banning commercial stem cell therapy for Autism Spectrum Disorder outside approved clinical trials, while outlining steps taken and future implementation plans
NIMS inaugurated a state-of-the-art stem cell laboratory in collaboration with Tulsi Therapeutics to promote advanced research in regenerative medicine and provide affordable stem cell and exosome therapies, especially for economically weaker sections
The LVPEI patented stem cell therapy holds promise to treat corneal scarring that happens when cornea, the transparent outer layer of the eye, gets damaged due to infections or accidents.
